Drug Monograph
Full clinical overview, indications, dosage references & safety notes.
Overview
Docusate (dioctyl sodium sulfosuccinate; DSS) is a surfactant stool softener used in dogs and cats to facilitate the passage of hard or dry feces. It is commonly used in cases of constipation or when defecation may be painful.
It acts locally within the gastrointestinal tract and is generally well tolerated at recommended doses. Docusate is typically administered orally and may be used alone in mild cases of constipation.
Mechanism of Action (MOA): Docusate reduces surface tension within fecal material, allowing water and lipids to penetrate the stool. This increases stool hydration and softness, facilitating easier passage. It may also increase fluid and electrolyte secretion in the colon, enhancing its stool-softening effect.
Indications
Docusate is used in dogs and cats as a stool softener to facilitate passage of hard or dry feces and reduce straining during defecation.
- Constipation: Used to soften hard, dry stools and facilitate easier defecation.
- Anorectal conditions: Indicated when passage of firm feces may be painful or detrimental (e.g., after surgery or with perianal disease).
- Fecal impaction (adjunctive use): May be used as part of management to soften impacted fecal material.
Dosage (Reference)
Dog
In dogs, docusate is administered orally as a stool softener. Dosing is based on the individual animal (not body weight) and should be adjusted according to size and clinical response.
| Clinical use | Route | Dose | Notes |
|---|---|---|---|
| Stool softener | PO | 25–100 mg/dog once to twice daily | Dose depends on dog size; not weight-based. |
| Large dogs (maximum range) | PO | Up to 240–250 mg/dog once daily | Used in very large dogs when clinically indicated. |
• Dose is expressed per animal (NOT mg/kg).
• Administer on an empty stomach (about 1 hour before or 2 hours after feeding).
• Adjust dose based on stool consistency and clinical response.
• Avoid excessive dosing to reduce risk of diarrhea or mucosal irritation.
Cat
In cats, docusate is administered orally as a stool softener using a fixed dose regimen.
| Clinical use | Route | Dose | Notes |
|---|---|---|---|
| Stool softener | PO | 50 mg/cat once daily | Fixed dose; not weight-based. |
• Dose is given per animal (NOT mg/kg).
• Administer on an empty stomach for optimal effect.
• Monitor stool consistency and adjust therapy as needed.
Warnings & Precautions
Docusate should be used cautiously in dogs and cats, with attention to underlying gastrointestinal conditions and fluid balance to minimize potential complications.
- Contraindication (hypersensitivity): Do not use in patients with known hypersensitivity to docusate.
- Fluid and electrolyte imbalance: Use with caution in patients with preexisting dehydration or electrolyte abnormalities, as alterations in fluid movement may worsen these conditions.
- Risk of aspiration: Use cautiously in patients at risk of aspiration, particularly when administering liquid formulations.
- Gastrointestinal irritation: May cause irritation of the gastrointestinal mucosa; avoid excessive dosing.
- Administration considerations: Oral liquid forms may cause throat irritation due to their bitter taste.
Drug Interactions
Clinically relevant interactions with docusate are primarily related to its surfactant properties, which may alter the absorption of other substances.
- Mineral oil: Concurrent use is not recommended in dogs and cats, as docusate may enhance systemic absorption of mineral oil, increasing the risk of adverse effects. If use together is deemed necessary, separate administration by at least 2 hours.
Side Effects & Overdose
Side Effects
Docusate is generally well tolerated in dogs and cats at recommended doses, but gastrointestinal adverse effects may occur.
- Gastrointestinal effects: Cramping and diarrhea may occur, especially with higher doses.
- Mucosal irritation: Potential for gastrointestinal mucosal damage with excessive use.
- Oral irritation: Liquid formulations may cause throat irritation due to bitter taste.
Overdose
Information on overdose in dogs and cats is limited, but excessive dosing may increase the severity of known gastrointestinal effects.
- Severe diarrhea and cramping.
- Dehydration and electrolyte imbalance: May occur secondary to excessive fluid loss.
- Gastrointestinal damage: High doses may increase risk of mucosal injury.
- Management: Discontinue the drug and provide supportive care, including fluid and electrolyte correction as needed.
Key Notes
Practical clinical considerations for the use of docusate in dogs and cats:
- Surfactant laxative: Works by altering stool consistency rather than stimulating intestinal motility.
- Onset of action: Effect may take time to develop, making it more suitable for mild to moderate constipation rather than acute obstruction.
- Not effective for severe impaction alone: May require combination with other therapies in more advanced cases.
- Palatability consideration: Bitter taste may affect compliance, particularly in cats.
- OTC availability: Widely available without prescription, but veterinary guidance is recommended before use.
